Home › Compare › Tirzepatide vs Cagrilintide + Semaglutide (CagriSema)
Tirzepatide vs Cagrilintide + Semaglutide (CagriSema)
Tirzepatide sits in metabolic / weight loss, while Cagrilintide + Semaglutide (CagriSema) sits in blends — so despite being mentioned together they are used for different things. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
TirzepatideMetabolic / Weight Loss
Cagrilintide + Semaglutide (CagriSema)BlendsAt a glance
| Tirzepatide | Cagrilintide + Semaglutide (CagriSema) | |
|---|---|---|
| Category | Metabolic / Weight Loss | Blends |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~56 days | — |
| Commonly reported effects | Aggressive fat loss Appetite reduction Insulin sensitivity | Combined in one vial Single reconstitution One shared shelf life |
| Reported considerations | Nausea Vomiting Diarrhea | As per either compound in the blend Gastrointestinal effects reported for both compounds |
The differences that actually matter
They aren't really substitutes: Tirzepatide sits in Metabolic / Weight Loss while Cagrilintide + Semaglutide (CagriSema) sits in Blends. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Reported mainly for Tirzepatide: aggressive fat loss, appetite reduction, insulin sensitivity.
Reported mainly for Cagrilintide + Semaglutide (CagriSema): combined in one vial, single reconstitution, one shared shelf life.
What Tirzepatide is
Tirzepatide functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both these incretin receptors, it synergistically enhances glucose-dependent insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells, particularly after meals. This dual action also contributes to a delay in gastric emptying, which helps to moderate postprandial glucose excursions and promotes a feeling of satiety. Its
What Cagrilintide + Semaglutide (CagriSema) is
Cagrilintide + Semaglutide is a blend designed to target two distinct but complementary metabolic pathways. Cagrilintide functions as an amylin analogue, engaging the amylin receptor, while Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. The amylin analogue slows gastric emptying, suppresses postprandial glucagon secretion, and contributes to satiety signaling. Semaglutide, with its extended half-life of approximately seven days due to albumin binding, enhances glucose-dependent insulin secr
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Tirzepatide and Cagrilintide + Semaglutide (CagriSema) are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Tirzepatide and Cagrilintide + Semaglutide (CagriSema)?
They aren't really substitutes: Tirzepatide sits in Metabolic / Weight Loss while Cagrilintide + Semaglutide (CagriSema) sits in Blends. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Can you log Tirzepatide and Cagrilintide + Semaglutide (CagriSema) in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Tirzepatide or Cagrilintide + Semaglutide (CagriSema)?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.